Achillion Pharmaceuticals, Inc.
(NASDAQ:ACHN)|
1.00 0.00 (0.00%) Dec 04 - Close |
|
|
|
After-Hours 1.00 0.00 (0.00%) Thu, 4 Dec 2008 7:40 PM
- Compare ACHN with:
- View: Line | Candlestick
Company Profile
Achillion Pharmaceuticals, Inc.
300 George Street
New Haven, CT 06511
United States - Map
Phone: (203) 624-7000
Fax: (203) 624-7003
Website: www.achillion.com
CEO: Michael D. Kishbauch
Employees: 60
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Dvlps innovativ treatments for infectious diseases
A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases.
Recent news for ACHN
-
Achillion Pharma: Hepatitis Drug Dev Pipeline Now Fully Funded
Seeking Alpha - Nov 25 at 3:16 ET
-
Achillion to Present At Lazard Capital Markets 5th Annual Healthcare Conference
GlobeNewswire - Nov 17 at 7:00 ET
-
ACHILLION PHARMACEUTICALS INC Financials
EDGAR Online Financials - Nov 01 at 8:04 ET
-
Zacks #1 Rank Additions for Thursday
Zacks.com - Oct 30 at 7:42 ET
-
Achillion Pharma downgraded by Oppenheimer
Briefing.com - Oct 30 at 5:55 ET
-
ACHILLION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Oct 29 at 2:01 ET
-
New Star Analyst Rankings for ACHILLION PHARMACEUT
StarMine - Oct 29 at 8:23 ET
-
EDGAR Online - Oct 28 at 4:09 ET
-
Achillion Reports Third Quarter 2008 Financial Results
GlobeNewswire - Oct 28 at 3:40 ET
-
Data From Achillion's Antibacterial and HIV Programs Presented At the 2008 ICAAC/IDSA Joint Meeting
GlobeNewswire - Oct 27 at 3:00 ET